CSS
PAVM icon

Cubist Systematic Strategies’s PAVmed PAVM Stock Holding History

Cubist Systematic Strategies’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,266
Closed -$1.4M – 3720
2021
Q4 		$1.4M Buy
+1,266
New +$2.75M 0.01% 1659
2021
Q3 		– Sell
-39
Closed -$113K – 3128
2021
Q2 		$113K Buy
39
+6
+18% +$14.2K ﹤0.01% 2705
2021
Q1 		$66K Buy
+33
New +$49.6K ﹤0.01% 2708

Other funds holding PAVM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cubist Systematic Strategies's PAVM Position: Q1 2022 in Review

Cubist Systematic Strategies sold out of PAVmed (PAVM) in Q1 2022, closing a stake of 1,266 shares — an estimated $1.4M sold.

Cubist Systematic Strategies first reported a position in PAVM in Q1 2021 and held it in 3 quarters. The position peaked at $1.4M in Q4 2021. 94 funds tracked by Wall St. Rank hold PAVM as of Q1 2022.

  • Cubist Systematic Strategies reported no remaining PAVmed position as of Q1 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,266 PAVmed shares in Q1 2022, an estimated $1.4M.
  • Cubist Systematic Strategies first reported a position in PAVmed in Q1 2021 and held it in 3 quarters.
  • Cubist Systematic Strategies's PAVmed position peaked at $1.4M in Q4 2021.
  • 94 funds tracked by Wall St. Rank held PAVmed as of Q1 2022.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.